Two key modulators emerged: a gene on chromosome 10 called Oprm1, which codes for a well-known opioid receptor; and a gene on chromosome 16 that codes for a signaling protein called fibroblast growth factor 12 (Fgf12), which has not previously been linked to opioid use disorder. This evidence concerns the gene FGF12 and opioid use disorder.